Evidence map›Paper›PMID 41216285›Full record

ArticleClinical case reports2025

From Resistance to Relief: IV Levothyroxine in Refractory Hypothyroidism Management.

Mohammad Amro, Elias Edward Lahham, Ahmed Jalal Sawafta, Motaz Saifi, Nooreddin Saifi, Fadi Atrash, Salem Billan

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad AmroFaculty of Medicine An Najah National University Nablus Palestine.ORCID https://orcid.org/0009-0006-6949-5779
Elias Edward LahhamDepartment of Radiation Oncology Augusta Victoria Hospital East Jerusalem Palestine.ORCID https://orcid.org/0000-0002-6514-5206
Ahmed Jalal SawaftaFaculty of Medicine An Najah National University Nablus Palestine.
Motaz SaifiFaculty of Medicine An Najah National University Nablus Palestine.
Nooreddin SaifiFaculty of Medicine An Najah National University Nablus Palestine.
Fadi AtrashDepartment of Radiation Oncology Augusta Victoria Hospital East Jerusalem Palestine.
Salem BillanHead and Neck Unit, Joseph Fishman Oncology Center Rambam Health Care Campus Haifa Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report details the clinical scenario of a 27-year-old female patient diagnosed with idiopathic refractory hypothyroidism. Despite adherence to prescribed oral levothyroxine therapy, she continued to experience persistent symptoms such as fatigue and cold intolerance. The exploration of her condition delved into the complexities of refractory hypothyroidism, encompassing both its diagnostic challenges and therapeutic management. A critical distinction was made between true levothyroxine malabsorption and pseudo-malabsorption, the latter being attributed to issues with medication adherence. The scarcity of research on intravenous levothyroxine use in such cases was noted, highlighting the novelty of this approach. The patient's favorable response to intravenous levothyroxine administration, marked by complete symptom resolution and sustained euthyroid state over four years, provides valuable insights. This case contributes significantly to the existing knowledge on the idiopathic etiologies of refractory hypothyroidism and advocates for the consideration of intravenous levothyroxine as an effective alternative when oral administration proves inadequate.

Indexed as

hypothyroidismintravenouslevothyroxinepseudo‐malabsorptive hypothyroidismrefractory hypothyroidism

Identifiers

PMID41216285
PMCPMC12597396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.